Shin Nippon Biomedical Laboratories Ltd 2395.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
721.00quote price arrow down-9.00 (-1.23%)
Volume
137,400
52 week range
537.00 - 855.00

...

Loading . . .
  • Open735.00
  • Day High735.00
  • Day Low720.00
  • Prev Close730.00
  • 52 Week High855.00
  • 52 Week High Date09/16/20
  • 52 Week Low537.00
  • 52 Week Low Date04/21/20

Key Stats

  • Market Cap269.66M
  • Shares Out41.63M
  • 10 Day Average Volume265,250
  • Dividend20.00
  • Dividend Yield2.77%
  • Beta
  • YTD % Change6.81

KEY STATS

  • Open735.00
  • Day High735.00
  • Day Low720.00
  • Prev Close730.00
  • 52 Week High855.00
  • 52 Week High Date09/16/20
  • 52 Week Low537.00
  • 52 Week Low Date04/21/20
  • Market Cap269.66M
  • Shares Out41.63M
  • 10 Day Average Volume265,250
  • Dividend20.00
  • Dividend Yield2.77%
  • Beta
  • YTD % Change6.81

RATIOS/PROFITABILITY

  • EPS (TTM)79.30
  • P/E (TTM)9.09
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/30/2020
  • Div Amount5.00
  • Split Date-
  • Split Factor-

Latest From Shin Nippon Biomedical Laboratories Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test...
Ryoichi Nagata
Chairman
Koichiro Fukuzaki
Vice Chairman
Ken Takanashi CPA
Chief Operating Officer
Address
28F, St Luke's Tower, 8-1, Akashi-cho
Chuo-ku, TKY
104-0044
Japan